These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22396537)

  • 1. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221.
    Santhekadur PK; Das SK; Gredler R; Chen D; Srivastava J; Robertson C; Baldwin AS; Fisher PB; Sarkar D
    J Biol Chem; 2012 Apr; 287(17):13952-8. PubMed ID: 22396537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).
    Rajasekaran D; Jariwala N; Mendoza RG; Robertson CL; Akiel MA; Dozmorov M; Fisher PB; Sarkar D
    J Biol Chem; 2016 May; 291(20):10736-46. PubMed ID: 26997225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
    Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
    Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
    Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H
    BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma.
    Yoo BK; Santhekadur PK; Gredler R; Chen D; Emdad L; Bhutia S; Pannell L; Fisher PB; Sarkar D
    Hepatology; 2011 May; 53(5):1538-48. PubMed ID: 21520169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness.
    Emdad L; Janjic A; Alzubi MA; Hu B; Santhekadur PK; Menezes ME; Shen XN; Das SK; Sarkar D; Fisher PB
    Neuro Oncol; 2015 Mar; 17(3):419-29. PubMed ID: 25216670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SND1 Regulates Organic Anion Transporter 2 Protein Expression and Sensitivity of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
    Wang Y; Wang Y; Fang Y; Jiang H; Yu L; Hu H; Zeng S
    Drug Metab Dispos; 2024 Aug; 52(9):997-1008. PubMed ID: 38960734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
    Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
    Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma.
    Cui X; Zhao C; Yao X; Qian B; Su C; Ren Y; Yao Z; Gao X; Yang J
    RNA Biol; 2018; 15(10):1364-1375. PubMed ID: 30321081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.
    Bao C; Li Y; Huan L; Zhang Y; Zhao F; Wang Q; Liang L; Ding J; Liu L; Chen T; Li J; Yao M; Huang S; He X
    Sci Signal; 2015 Jul; 8(387):ra75. PubMed ID: 26221053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
    Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
    J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
    EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL16 induces angiogenesis in autocrine signaling pathway involving hypoxia-inducible factor 1α in human umbilical vein endothelial cells.
    Yu X; Zhao R; Lin S; Bai X; Zhang L; Yuan S; Sun L
    Oncol Rep; 2016 Mar; 35(3):1557-65. PubMed ID: 26707275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.
    Zhang X; Liu S; Hu T; Liu S; He Y; Sun S
    Hepatology; 2009 Aug; 50(2):490-9. PubMed ID: 19472311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranscriptional Inhibition of Protein Tyrosine Phosphatase Nonreceptor Type 23 by Staphylococcal Nuclease and Tudor Domain Containing 1: Implications for Hepatocellular Carcinoma.
    Jariwala N; Mendoza RG; Garcia D; Lai Z; Subler MA; Windle JJ; Mukhopadhyay ND; Fisher PB; Chen Y; Sarkar D
    Hepatol Commun; 2019 Sep; 3(9):1258-1270. PubMed ID: 31497746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma.
    Wright T; Wang Y; Stratton SA; Sebastian M; Liu B; Johnson DG; Bedford MT
    Biochem J; 2023 Nov; 480(22):1805-1816. PubMed ID: 37905668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.